| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.390 | None | 1.000 | 9 | 0 | 2001 | 2018 | ||||||||
|
SET nuclear proto-oncogene | 0.507 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 1992 | 2010 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1992 | 2019 | ||||||||
|
TAL bHLH transcription factor 1, erythroid differentiation factor | 0.505 | 0.731 | 0.57 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1989 | 2019 | ||||||||
|
keratin 7 | 0.463 | 0.808 | 3.1E-12 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1989 | 2017 | ||||||||
|
selenocysteine lyase | 0.530 | 0.731 | 2.3E-09 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1989 | 2017 | ||||||||
|
CD38 molecule | 0.407 | 0.885 | 2.3E-06 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2011 | 2019 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1995 | 2019 | ||||||||
|
homeobox A9 | 0.521 | 0.692 | 4.4E-05 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2017 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 1987 | 1995 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2018 | ||||||||
|
Meis homeobox 1 | 0.579 | 0.615 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2007 | 2017 | ||||||||
|
eukaryotic translation initiation factor 4E | 0.448 | 0.846 | 0.94 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2013 | ||||||||
|
adhesion G protein-coupled receptor E5 | 0.601 | 0.538 | 3.1E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
T-box transcription factor 1 | 0.433 | 0.808 | 0.84 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2011 | ||||||||
|
DEK proto-oncogene | 0.542 | 0.769 | 0.13 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1992 | 2007 | ||||||||
|
adhesion G protein-coupled receptor E2 | 0.581 | 0.615 | 2.8E-28 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
lysine demethylase 1A | 0.512 | 0.808 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2016 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
nucleoporin 214 | 0.638 | 0.385 | 5.5E-02 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2007 | 2010 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2008 | 2016 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2013 | ||||||||
|
protein kinase AMP-activated catalytic subunit alpha 1 | 0.453 | 0.846 | 0.14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1 | 0.505 | 0.808 | 1.8E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
protein kinase C eta | 0.653 | 0.577 | 0.43 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 |